ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in Chicago, IL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Coronavirus Infections
Infections
Post-Acute COVID-19 Syndrome
Human Influenza
Pneumonia
Virus Diseases
Respiratory Tract Infections

COVID-19 trials near Chicago, IL, USA:

Status recently updated

Study of VYD2311 for the Prevention of COVID-19 (DECLARATION)

The main purpose of this study is to test an investigational drug known as VYD2311, which is being developed to lower the risk of getting COVID...

Enrolling
Active, not recruiting
COVID-19
Drug: VYD2311-SD
Drug: VYD2311-MD

Phase 3

Invivyd

Melrose Park, Illinois, United States and 19 other locations

IV compared to remdesivir IV alone for the treatment of symptomatic COVID-19 in severely immunocompromised adult participants who a...

Enrolling
COVID-19 Infection
Drug: remdesivir
Drug: placebo for ibuzatrelvir

Phase 3

Pfizer
Pfizer

Chicago, Illinois, United States and 116 other locations

Double-Blind, Randomized, Placebo-Controlled Study to Investigate the Safety and Efficacy of STRI Formula in Non-Hospitalized Participants with COVID...

Enrolling
Covid19
Drug: STRI Formula
Drug: Placebo

Phase 2

Eyecheck

Oak Forest, Illinois, United States and 12 other locations

of the study is to assess the safety and immunogenicity of IIV-HD (high-dose inactivated influenza vaccine) + rC19 (adjuvanted recombinant COVID...

Active, not recruiting
COVID-19 Immunization
Influenza Immunization
Biological: IIV-HD + rC19 (dose 4)
Biological: IIV-HD + rC19 (dose 3)

Phase 1, Phase 2

Sanofi
Sanofi

Chicago, Illinois, United States and 11 other locations

vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID-19).In order to represent a more recently circulating SAR...

Active, not recruiting
COVID-19
SARS-CoV2
Biological: VXA-CoV2-3.1
Biological: VXA-CoV2-3.3

Phase 2

Vaxart

Chicago, Illinois, United States and 144 other locations

The purpose of this study is to learn about the safety, tolerability, and immunogenicity of an updated vaccine against COVID-19, ca-...

Active, not recruiting
COVID-19
SARS-COV-2 Infection
Biological: BNT162b2 (2025/2026 formulation)

Phase 3

BioNTech
BioNTech

Oak Brook, Illinois, United States and 30 other locations

seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...

Enrolling
COVID-19
Parainfluenza
Drug: DAS181 COVID-19
Drug: DAS181

Phase 3

Ansun Biopharma

Chicago, Illinois, United States and 66 other locations

Researchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most oft-...

Enrolling
Coronavirus Disease (COVID-19)
Drug: Placebo
Drug: Molnupiravir

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Chicago, Illinois, United States and 217 other locations

study treatment works in the study) of the study medicine (called nirmatrelvir/ritonavir) for potential treatment of coronavirus disease 2019 (COVID...

Enrolling
COVID-19
Drug: nirmatrelvir
Drug: ritonavir

Phase 3

Pfizer
Pfizer

Chicago, Illinois, United States and 75 other locations

This study is a Phase 3 trial designed to check the safety and immune response to a new Omicron JN.1 COVID-19 vaccine. Study resear-...

Active, not recruiting
COVID-19
SARS-CoV-2 Infection
Biological: NVX-CoV2705

Phase 3

Sanofi
Sanofi

Melrose Park, Illinois, United States and 9 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems